key: cord-1042227-mc260z94 authors: Jiang, Lina; Wang, Jing; Yu, Bin; Ning, Chuanyi; Tan, Yi title: Potential dual outbreak of COVID-19 and HFMD among children in Asia-pacific countries in the HFMD-endemic area date: 2020-12-30 journal: Biosaf Health DOI: 10.1016/j.bsheal.2020.12.004 sha: 06357bb59e690eb80f3db7b1494f94a8e46b4b63 doc_id: 1042227 cord_uid: mc260z94 • We assume that HFMD cases would probably increase and develop the same pattern as people returning to work and children returning to school or day-care. • It's indispensable to alert the dual outbreak of COVID-19 and HFMD in the coming season. In the era of the pandemic of coronavirus disease 2019 (COVID-19), the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects infants and children with mild or atypical symptoms [1, 2] . The new variations in SARS-CoV-2 recently found in the United Kingdom greatly increased the risk of infection among children [3] . Although previous evidence showed that children rarely developed severe symptoms from COVID-19, the hospitalization rate was 24.5% and the ICU admission rate was 2.5% among children in the United States[4]. Further, there is a lack of evidence regarding the influence of the recently appeared SARS-CoV-2 variations. Thus, it is of great significance to monitor and track the COVID-19 infection among children. As of 22 December 2020, a total of 1,006,682 cases had been reported in Western Pacific countries, including 18,895 deaths reports [5] . Evidence showed that COVID-19 targeted strategies as city lockdown and social distancing had made an essential contribution to this disease's constraint and some other communicable diseases, including hand, foot, and mouth disease (HFMD) and influenza, etc. HFMD inflicts harm, most commonly among children under five years old, which has caused 96 900 (40 600-259 000) annual losses on DALYs (number of years lost due to specific disease) in Asia-pacific countries [6] . Although daily numbers of infections have greatly declined, small outbreaks still happens in Asia countries. The coming season is most alarmingly the peak incidence of HFMD in many Asia-pacific countries [6] . In light of the growing concern over the consequences of combined HFMD and COVID-19 epidemics, it is of great J o u r n a l P r e -p r o o f Journal Pre-proof significance to consider and devise prevention strategies against the two viruses. Based on the evidence from the outbreaks over the past years, most probably the HFMD cases would increase and develop the similar pattern in the coming season as people returning to work and children returning to school or daycare settings. Although the pandemic of COVID-19 in Asian countries have been brought under control, given the risk of the outbreaks caused by imported cases in Asia-pacific countries in the HFMD-endemic area, it is indispensable to consider the possibility of dual attack of COVID-19 and HFMD in the coming season . We assumed that the outbreak of COVID-19 mainly occurred from January to March, while the previous studies indicated that the HFMD infection substantially increased during February and May [6] . It is highly possible that there may exist the co-infection of COVID-19 and HFMD in the spring. Additionally, the COVID-19 and HFMD shared some of the pathways, including respiratory droplets and hands-oral pathway. Further, our previous studies have shown that, the highest incidence of HFMD occur among children aged one year and younger [7] . In China, the reported mean annual severe illness rate was 11.8 (95% CI: 11.7-11.8) per one million person-years, with the yearly mortality rate as 0.308 (95% CI: 0.307-0.310) per one million person-years [8] . HFMD causes a substantial disease burden in young children. During the early stages of the COVID-19 outbreak, children were considered to be rarely infected by SARS-CoV-2 due to the lower exposure [9] . However, the recent new virus variation increased the risk of infection among children [3] . Further, infants and young children develop a relatively more severe illness than older children [10] . Hence it raises J o u r n a l P r e -p r o o f Journal Pre-proof concern on treatment and management of children the co-infected of HFMD and COVID-19. So far, there has no report about co-infection of HFMD and COVID-19 , co-infection of COVID-19 and dengue virus, [11] or COVID-19 and influenza virus [12] , alerting us that children may be simultaneously infected with both SARS-CoV-2 and enterovirus, particularly infant and young children who may develop severe symptoms and signs. The proportion of asymptomatic SARS-CoV-2 infection among children reached up to 35%. Children with asymptomatic infection usually have high viral loads of SARS-CoV-2 with prolonged fecal-shedding that causing nosocomial infection or pandemic to happen among the hospitalized severe HFMD cases [13] . Besides, the household transmission is another subject of concern regarding HFMD or COVID-19 infections. It is critical to block this transmission route. In summary, it is challenging to prevent HFMD during the COVID-19 pandemic. Many healthcare staff has been redistributed to fight for the COVID-19 epidemics, leading to a shortage of public health and medical resources. Furthermore, the fear of COVID-19 infection in the hospital may hinder the early visits to the medical settings, thus increase the severity of the illness. The co-infection of HFMD and COVID-19 would be more severe in aggravating the burden of healthcare systems. Other than measures as social distancing with timely treatment, regular cleaning, and disinfection, and prevention of the shared pathways (mask wearing, hands wash, etc.) to prevent HFMD and COVID-19, we also strongly recommend using more accurate, rapid, and accessible diagnostic techniques include real-time reverse transcription-polymerase J o u r n a l P r e -p r o o f Journal Pre-proof chain reaction assays to identify SARS-CoV-2 patients with asymptomatic infection at the early stage. Specific guidelines for diagnosing and treating COVID-19 and HFMD co-infection, as well as COVID-19 and influenza con-infection, are expected to be in place soon.. Considering the well-control of COVID-19 in some Asian-Pacific countries, it is suggestive for the countries that still under the influence of COVID-19 to consider the risk and prevention of COVID-19 and HFMD infection, as well as that of influenza and COVID-19. Coronavirus disease 2019 in children: Current status COVID-19 in 7780 pediatric patients: A systematic review Severity and burden of hand, foot and mouth disease in Asia: a modelling study Effectiveness of enterovirus A71 vaccine in severe hand, foot, and mouth disease cases in Guangxi, China Epidemiology of hand, foot and mouth disease in China Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention COVID-19 in Children: Clinical Approach and Management Covert COVID-19 and false-positive dengue serology in Singapore A Case Series of Patients Coinfected With Influenza and COVID-19 COVID-19 in Children, Pregnancy and Neonates: A Review of Epidemiologic and Clinical Features We would like to thank all staff in the local Center for Disease Control and Prevention (CDC) and HFMD Sentinel hospital in China for assisting with data collection. This work was supported by the Guangxi Natural Science Foundation (2017JJA140773y). The authors declare that there is no conflict of interest.